2.4.1.9 Html 420 517 1 true 124 0 false 12 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.themedicinescompany.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.themedicinescompany.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 1001001 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.themedicinescompany.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 1002000 - Statement - Consolidated Statements of Income Sheet http://www.themedicinescompany.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income false false R5.htm 1003000 - Statement - Consolidated Statement of Comprehensive Income Sheet http://www.themedicinescompany.com/role/ConsolidatedStatementOfComprehensiveIncome Consolidated Statement of Comprehensive Income false false R6.htm 1003000 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.themedicinescompany.com/role/ConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity false false R7.htm 1004000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.themedicinescompany.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R8.htm 2101100 - Disclosure - Nature of Business Sheet http://www.themedicinescompany.com/role/NatureOfBusiness Nature of Business false false R9.htm 2101100 - Disclosure - Significant Accounting Policies Sheet http://www.themedicinescompany.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R10.htm 2102100 - Disclosure - Inventory Sheet http://www.themedicinescompany.com/role/Inventory Inventory false false R11.htm 2103100 - Disclosure - Fixed Assets Sheet http://www.themedicinescompany.com/role/FixedAssets Fixed Assets false false R12.htm 2104100 - Disclosure - Cash, Cash Equivalents and Restricted Cash Sheet http://www.themedicinescompany.com/role/CashCashEquivalentsAndRestrictedCash Cash, Cash Equivalents and Restricted Cash false false R13.htm 2105100 - Disclosure - Non Marketable Investments Sheet http://www.themedicinescompany.com/role/NonMarketableInvestments Non Marketable Investments false false R14.htm 2106100 - Disclosure - Acquisitions Sheet http://www.themedicinescompany.com/role/Acquisitions Acquisitions false false R15.htm 2107100 - Disclosure - Intangible Assets and Goodwill Sheet http://www.themedicinescompany.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill false false R16.htm 2108100 - Disclosure - Accrued Expenses Sheet http://www.themedicinescompany.com/role/AccruedExpenses Accrued Expenses false false R17.htm 2109100 - Disclosure - Convertible Senior Notes Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotes Convertible Senior Notes false false R18.htm 2110100 - Disclosure - Stockholders' Equity Sheet http://www.themedicinescompany.com/role/StockholdersEquity Stockholders' Equity false false R19.htm 2111100 - Disclosure - Share-Based Compensation Sheet http://www.themedicinescompany.com/role/ShareBasedCompensation Share-Based Compensation false false R20.htm 2112100 - Disclosure - Earnings per Share Sheet http://www.themedicinescompany.com/role/EarningsPerShare Earnings per Share false false R21.htm 2113100 - Disclosure - Income Taxes Sheet http://www.themedicinescompany.com/role/IncomeTaxes Income Taxes false false R22.htm 2114100 - Disclosure - Fair Value Measurements Sheet http://www.themedicinescompany.com/role/FairValueMeasurements Fair Value Measurements false false R23.htm 2116100 - Disclosure - Restructuring Costs and Other, Net Sheet http://www.themedicinescompany.com/role/RestructuringCostsAndOtherNet Restructuring Costs and Other, Net false false R24.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.themedicinescompany.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R25.htm 2118100 - Disclosure - Employee Benefit Plan Sheet http://www.themedicinescompany.com/role/EmployeeBenefitPlan Employee Benefit Plan false false R26.htm 2119100 - Disclosure - Segment and Geographic Information Sheet http://www.themedicinescompany.com/role/SegmentAndGeographicInformation Segment and Geographic Information false false R27.htm 2120100 - Disclosure - Collaboration Agreements Sheet http://www.themedicinescompany.com/role/CollaborationAgreements Collaboration Agreements false false R28.htm 2121100 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.themedicinescompany.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss false false R29.htm 2122100 - Disclosure - Subsequent Events Sheet http://www.themedicinescompany.com/role/SubsequentEvents Subsequent Events false false R30.htm 2123100 - Disclosure - Selected Quarterly Financial Data Sheet http://www.themedicinescompany.com/role/SelectedQuarterlyFinancialData Selected Quarterly Financial Data false false R31.htm 2201201 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.themedicinescompany.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R32.htm 2301302 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.themedicinescompany.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) false false R33.htm 2302301 - Disclosure - Inventory (Tables) Sheet http://www.themedicinescompany.com/role/InventoryTables Inventory (Tables) false false R34.htm 2303301 - Disclosure - Fixed Assets Fixed Assets (Tables) Sheet http://www.themedicinescompany.com/role/FixedAssetsFixedAssetsTables Fixed Assets Fixed Assets (Tables) false false R35.htm 2306301 - Disclosure - Acquisitions Acquisitions (Tables) Sheet http://www.themedicinescompany.com/role/AcquisitionsAcquisitionsTables Acquisitions Acquisitions (Tables) false false R36.htm 2307301 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://www.themedicinescompany.com/role/IntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) false false R37.htm 2308301 - Disclosure - Accrued Expenses Accrued Expenses (Tables) Sheet http://www.themedicinescompany.com/role/AccruedExpensesAccruedExpensesTables Accrued Expenses Accrued Expenses (Tables) false false R38.htm 2309301 - Disclosure - Convertible Senior Notes (Tables) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesTables Convertible Senior Notes (Tables) false false R39.htm 2311301 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.themedicinescompany.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) false false R40.htm 2312301 - Disclosure - Earnings per Share (Tables) Sheet http://www.themedicinescompany.com/role/EarningsPerShareTables Earnings per Share (Tables) false false R41.htm 2313301 - Disclosure - Income Taxes (Tables) Sheet http://www.themedicinescompany.com/role/IncomeTaxesTables Income Taxes (Tables) false false R42.htm 2314301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.themedicinescompany.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R43.htm 2316301 - Disclosure - Restructuring Costs and Other, Net (Tables) Sheet http://www.themedicinescompany.com/role/RestructuringCostsAndOtherNetTables Restructuring Costs and Other, Net (Tables) false false R44.htm 2317301 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.themedicinescompany.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R45.htm 2319301 - Disclosure - Segment and Geographic Information (Tables) Sheet http://www.themedicinescompany.com/role/SegmentAndGeographicInformationTables Segment and Geographic Information (Tables) false false R46.htm 2321301 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.themedicinescompany.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) false false R47.htm 2323301 - Disclosure - Selected Quarterly Financial Data Selected Quarterly Financial Data (Tables) Sheet http://www.themedicinescompany.com/role/SelectedQuarterlyFinancialDataSelectedQuarterlyFinancialDataTables Selected Quarterly Financial Data Selected Quarterly Financial Data (Tables) false false R48.htm 2401401 - Disclosure - Nature of Business (Details) Sheet http://www.themedicinescompany.com/role/NatureOfBusinessDetails Nature of Business (Details) false false R49.htm 2401403 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.themedicinescompany.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) false false R50.htm 2401404 - Disclosure - Significant Accounting Policies Sales Allowances and Accruals (Details) Sheet http://www.themedicinescompany.com/role/SignificantAccountingPoliciesSalesAllowancesAndAccrualsDetails Significant Accounting Policies Sales Allowances and Accruals (Details) false false R51.htm 2402402 - Disclosure - Inventory (Details) Sheet http://www.themedicinescompany.com/role/InventoryDetails Inventory (Details) false false R52.htm 2403402 - Disclosure - Fixed Assets Fixed Assets (Details) Sheet http://www.themedicinescompany.com/role/FixedAssetsFixedAssetsDetails Fixed Assets Fixed Assets (Details) false false R53.htm 2404401 - Disclosure - Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.themedicinescompany.com/role/CashCashEquivalentsAndRestrictedCashCashCashEquivalentsAndRestrictedCashDetails Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted Cash (Details) false false R54.htm 2405401 - Disclosure - Non Marketable Investments Non Marketable Investments (Details) Sheet http://www.themedicinescompany.com/role/NonMarketableInvestmentsNonMarketableInvestmentsDetails Non Marketable Investments Non Marketable Investments (Details) false false R55.htm 2406402 - Disclosure - Acquisitions (Incline Therapeutics, Inc.) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsInclineTherapeuticsIncDetails Acquisitions (Incline Therapeutics, Inc.) (Details) false false R56.htm 2406403 - Disclosure - Acquisitions (Recothrom) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsRecothromDetails Acquisitions (Recothrom) (Details) false false R57.htm 2406404 - Disclosure - Acquisitions (ProFibrix B.V.) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsProfibrixBVDetails Acquisitions (ProFibrix B.V.) (Details) false false R58.htm 2406405 - Disclosure - Acquisitions (Rempex Pharmaceuticals, Inc.) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsRempexPharmaceuticalsIncDetails Acquisitions (Rempex Pharmaceuticals, Inc.) (Details) false false R59.htm 2406406 - Disclosure - Acquisitions (Tenaxis Medical, Inc) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsTenaxisMedicalIncDetails Acquisitions (Tenaxis Medical, Inc) (Details) false false R60.htm 2406407 - Disclosure - Acquisitions (Pro Forma) (Details) Sheet http://www.themedicinescompany.com/role/AcquisitionsProFormaDetails Acquisitions (Pro Forma) (Details) false false R61.htm 2407402 - Disclosure - Intangible Assets and Goodwill (Details) Sheet http://www.themedicinescompany.com/role/IntangibleAssetsAndGoodwillDetails Intangible Assets and Goodwill (Details) false false R62.htm 2407403 - Disclosure - Intangible Assets and Goodwill Goodwill (Details) Sheet http://www.themedicinescompany.com/role/IntangibleAssetsAndGoodwillGoodwillDetails Intangible Assets and Goodwill Goodwill (Details) false false R63.htm 2408402 - Disclosure - Accrued Expenses Accrued Expenses (Details) Sheet http://www.themedicinescompany.com/role/AccruedExpensesAccruedExpensesDetails Accrued Expenses Accrued Expenses (Details) false false R64.htm 2409402 - Disclosure - Convertible Senior Notes (Details) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesDetails Convertible Senior Notes (Details) false false R65.htm 2409403 - Disclosure - Convertible Senior Notes (Liability Component) (Details) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesLiabilityComponentDetails Convertible Senior Notes (Liability Component) (Details) false false R66.htm 2409404 - Disclosure - Convertible Senior Notes (Interest Expense) (Details) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesInterestExpenseDetails Convertible Senior Notes (Interest Expense) (Details) false false R67.htm 2409405 - Disclosure - Convertible Senior Notes (Note Hedges) (Details) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesNoteHedgesDetails Convertible Senior Notes (Note Hedges) (Details) false false R68.htm 2409406 - Disclosure - Convertible Senior Notes (Warrants) (Details) Notes http://www.themedicinescompany.com/role/ConvertibleSeniorNotesWarrantsDetails Convertible Senior Notes (Warrants) (Details) false false R69.htm 2410401 - Disclosure - Stockholders' Equity Stockholders' Equity (Details) Sheet http://www.themedicinescompany.com/role/StockholdersEquityStockholdersEquityDetails Stockholders' Equity Stockholders' Equity (Details) false false R70.htm 2411402 - Disclosure - Share-Based Compensation (Details) Sheet http://www.themedicinescompany.com/role/ShareBasedCompensationDetails Share-Based Compensation (Details) false false R71.htm 2411403 - Disclosure - Share-Based Compensation (Stock Option Activity) (Details) Sheet http://www.themedicinescompany.com/role/ShareBasedCompensationStockOptionActivityDetails Share-Based Compensation (Stock Option Activity) (Details) false false R72.htm 2411404 - Disclosure - Share-Based Compensation (Weighted Average Assumptions) (Details) Sheet http://www.themedicinescompany.com/role/ShareBasedCompensationWeightedAverageAssumptionsDetails Share-Based Compensation (Weighted Average Assumptions) (Details) false false R73.htm 2411405 - Disclosure - Share-Based Compensation (Restricted Stock Awards) (Details) Sheet http://www.themedicinescompany.com/role/ShareBasedCompensationRestrictedStockAwardsDetails Share-Based Compensation (Restricted Stock Awards) (Details) false false R74.htm 2412402 - Disclosure - Earnings per Share (Details) Sheet http://www.themedicinescompany.com/role/EarningsPerShareDetails Earnings per Share (Details) false false R75.htm 2413402 - Disclosure - Income Taxes (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesDetails Income Taxes (Details) false false R76.htm 2413403 - Disclosure - Income Taxes (Benefit From (Provision) Income Taxes) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesBenefitFromProvisionIncomeTaxesDetails Income Taxes (Benefit From (Provision) Income Taxes) (Details) false false R77.htm 2413404 - Disclosure - Income Taxes (Components of Income Before Income Taxes) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesComponentsOfIncomeBeforeIncomeTaxesDetails Income Taxes (Components of Income Before Income Taxes) (Details) false false R78.htm 2413405 - Disclosure - Income Taxes (Effective Income Tax Rate Reconciliation) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails Income Taxes (Effective Income Tax Rate Reconciliation) (Details) false false R79.htm 2413406 - Disclosure - Income Taxes (Deferred Tax Assets) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesDeferredTaxAssetsDetails Income Taxes (Deferred Tax Assets) (Details) false false R80.htm 2413407 - Disclosure - Income Taxes (Tax Expiration) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesTaxExpirationDetails Income Taxes (Tax Expiration) (Details) false false R81.htm 2413408 - Disclosure - Income Taxes (Unrecognized Tax Benefits) (Details) Sheet http://www.themedicinescompany.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails Income Taxes (Unrecognized Tax Benefits) (Details) false false R82.htm 2414402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.themedicinescompany.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R83.htm 2414403 - Disclosure - Fair Value Measurements (Level 3 Inputs) (Details) Sheet http://www.themedicinescompany.com/role/FairValueMeasurementsLevel3InputsDetails Fair Value Measurements (Level 3 Inputs) (Details) false false R84.htm 2414404 - Disclosure - Fair Value Measurements (Level 3 Contingent Purchase Price) (Details) Sheet http://www.themedicinescompany.com/role/FairValueMeasurementsLevel3ContingentPurchasePriceDetails Fair Value Measurements (Level 3 Contingent Purchase Price) (Details) false false R85.htm 2416402 - Disclosure - Restructuring Costs and Other, Net (Details) Sheet http://www.themedicinescompany.com/role/RestructuringCostsAndOtherNetDetails Restructuring Costs and Other, Net (Details) false false R86.htm 2417402 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.themedicinescompany.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R87.htm 2418401 - Disclosure - Employee Benefit Plan Employee Benefit Plan (Details) Sheet http://www.themedicinescompany.com/role/EmployeeBenefitPlanEmployeeBenefitPlanDetails Employee Benefit Plan Employee Benefit Plan (Details) false false R88.htm 2419402 - Disclosure - Segment and Geographic Information (Details) Sheet http://www.themedicinescompany.com/role/SegmentAndGeographicInformationDetails Segment and Geographic Information (Details) false false R89.htm 2420401 - Disclosure - Collaboration Agreements (Details) Sheet http://www.themedicinescompany.com/role/CollaborationAgreementsDetails Collaboration Agreements (Details) false false R90.htm 2421402 - Disclosure - Accumulated Other Comprehensive Loss (Details) Sheet http://www.themedicinescompany.com/role/AccumulatedOtherComprehensiveLossDetails Accumulated Other Comprehensive Loss (Details) false false R91.htm 2422401 - Disclosure - Subsequent Events Convertible Senior Notes (Details) Notes http://www.themedicinescompany.com/role/SubsequentEventsConvertibleSeniorNotesDetails Subsequent Events Convertible Senior Notes (Details) false false R92.htm 2422402 - Disclosure - Subsequent Events Annovation (Details) Sheet http://www.themedicinescompany.com/role/SubsequentEventsAnnovationDetails Subsequent Events Annovation (Details) false false R93.htm 2422403 - Disclosure - Subsequent Events Recothrom (Details) Sheet http://www.themedicinescompany.com/role/SubsequentEventsRecothromDetails Subsequent Events Recothrom (Details) false false R94.htm 2423402 - Disclosure - Selected Quarterly Financial Data Selected Quarterly Financial Data (Details) Sheet http://www.themedicinescompany.com/role/SelectedQuarterlyFinancialDataSelectedQuarterlyFinancialDataDetails Selected Quarterly Financial Data Selected Quarterly Financial Data (Details) false false All Reports Book All Reports Element mdco_CollaborativeArrangementCashPayment had a mix of decimals attribute values: -6 -5. Element mdco_CollaborativeArrangementPaymentforMilestoneMet1 had a mix of decimals attribute values: -6 -5 0. Element mdco_CoPomotionIncome had a mix of decimals attribute values: -5 -3. Element mdco_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesCountedinSharePool had a mix of decimals attribute values: 1 2. Element us-gaap_AreaOfRealEstateProperty had a mix of decimals attribute values: -3 0. Element us-gaap_DebtInstrumentConvertibleConversionRatio1 had a mix of decimals attribute values: 0 4. Element us-gaap_DebtInstrumentFaceAmount had a mix of decimals attribute values: -3 0. Element us-gaap_FairValueInputsDiscountRate had a mix of decimals attribute values: 2 4. Element us-gaap_FairValueInputsProbabilityOfDefault had a mix of decimals attribute values: 2 4. Element us-gaap_GainLossRelatedToLitigationSettlement had a mix of decimals attribute values: -5 -3. Element us-gaap_PaymentsForRestructuring had a mix of decimals attribute values: -5 -3. Element us-gaap_PaymentsToAcquireBusinessesGross had a mix of decimals attribute values: -5 -3. Element us-gaap_PaymentsToAcquireIntangibleAssets had a mix of decimals attribute values: -5 -3. Element us-gaap_SeniorNotes had a mix of decimals attribute values: -5 -3. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 3 4. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate had a mix of decimals attribute values: 2 4 5. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice had a mix of decimals attribute values: 1 2. Element us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans had a mix of decimals attribute values: -3 0. Element us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross had a mix of decimals attribute values: -3 0. Element us-gaap_TaxCreditCarryforwardAmount had a mix of decimals attribute values: -5 -3. 'Shares' elements on report '1003000 - Statement - Consolidated Statements of Stockholders' Equity' had a mix of different decimal attribute values. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '1/1/2013 - 3/31/2013' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '4/1/2013 - 6/30/2013' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '7/1/2013 - 9/30/2013' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '1/1/2014 - 3/31/2014' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '4/1/2014 - 6/30/2014' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '7/1/2014 - 9/30/2014' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 365 days and at least 46 values. Shorter duration columns must have at least one fourth (11) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 2 values, so it is being removed. 'Monetary' elements on report '2401403 - Disclosure - Significant Accounting Policies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2403402 - Disclosure - Fixed Assets Fixed Assets (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2404401 - Disclosure - Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted Cash (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2406402 - Disclosure - Acquisitions (Incline Therapeutics, Inc.) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2406403 - Disclosure - Acquisitions (Recothrom) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2406404 - Disclosure - Acquisitions (ProFibrix B.V.) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2406405 - Disclosure - Acquisitions (Rempex Pharmaceuticals, Inc.) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2406406 - Disclosure - Acquisitions (Tenaxis Medical, Inc) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2407402 - Disclosure - Intangible Assets and Goodwill (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2409402 - Disclosure - Convertible Senior Notes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2409403 - Disclosure - Convertible Senior Notes (Liability Component) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2410401 - Disclosure - Stockholders' Equity Stockholders' Equity (Details)' had a mix of different decimal attribute values. 'Shares' elements on report '2412402 - Disclosure - Earnings per Share (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2413402 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2414404 - Disclosure - Fair Value Measurements (Level 3 Contingent Purchase Price) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2416402 - Disclosure - Restructuring Costs and Other, Net (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2417402 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2420401 - Disclosure - Collaboration Agreements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2422402 - Disclosure - Subsequent Events Annovation (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2422403 - Disclosure - Subsequent Events Recothrom (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '2423402 - Disclosure - Selected Quarterly Financial Data Selected Quarterly Financial Data (Details)' had a mix of different decimal attribute values. Process Flow-Through: 1001000 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 1001001 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 1002000 - Statement - Consolidated Statements of Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 1003000 - Statement - Consolidated Statement of Comprehensive Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 1004000 - Statement - Consolidated Statements of Cash Flows mdco-20141231.xml mdco-20141231.xsd mdco-20141231_cal.xml mdco-20141231_def.xml mdco-20141231_lab.xml mdco-20141231_pre.xml true true